BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Michalak A, Cichoż-Lach H, Guz M, Kozicka J, Cybulski M, Jeleniewicz W. Plateletcrit and Mean Platelet Volume in the Evaluation of Alcoholic Liver Cirrhosis and Nonalcoholic Fatty Liver Disease Patients. Biomed Res Int 2021;2021:8867985. [PMID: 33644233 DOI: 10.1155/2021/8867985] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Nelaturi P, Kademani SP, Siva Subramanian V, Ravikumar S. Noninvasive Biomarkers for Alcohol-Related Liver Disease—A Proteomic Related Preliminary Report. Ind J Clin Biochem 2023. [DOI: 10.1007/s12291-023-01120-9] [Reference Citation Analysis]
2 Marques P, Francisco V, Martínez-Arenas L, Carvalho-Gomes Â, Domingo E, Piqueras L, Berenguer M, Sanz MJ. Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease. Int J Mol Sci 2023;24. [PMID: 36768637 DOI: 10.3390/ijms24032313] [Reference Citation Analysis]
3 Ding JN, Feng TT, Sun W, Cai XY, Zhang Y, Zhao WF. Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study. World J Gastrointest Surg 2022; 14(11): 1260-1271 [DOI: 10.4240/wjgs.v14.i11.1260] [Reference Citation Analysis]
4 Xu W, Li B, Yang Z, Li J, Liu F, Liu Y. Rethinking Liver Fibrosis Staging in Patients with Hepatocellular Carcinoma: New Insights from a Large Two-Center Cohort Study. J Hepatocell Carcinoma 2022;9:751-81. [PMID: 35983561 DOI: 10.2147/JHC.S372577] [Reference Citation Analysis]